News

BioPharma Dive1d
Draig, a brain drug startup, debuts with $140M to treat depression
The funds will support Phase 2 testing of a drug the company believes to be able to safety home in on AMPA receptors, an ...
Timeslife on MSN3d
Feeling Burnt Out? Sip These 6 Natural Teas That Calm in Minutes
In our constantly connected world, stress and burnout have become pervasive. Long workdays, personal obligations, social ...
Neurology Advisor6d
Neurosteroids: A Novel Therapeutic Approach for Mood and Neurological Disorders
Neurosteroids demonstrate significant therapeutic promise through the modulation of the GABA system and warrant further investigation.
clinicaladvisor.com8d
Pharmacovigilance Assessment of Compounded GLP-1 Receptor Agonists: Insights From the FDA Adverse Event Reporting System
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have revolutionized the management of metabolic diseases, offering substantial benefits in glycemic control, weight reduction, cardiovascular ...
C&EN10d
Discovery, Structure–Activity Relationships, and In Vivo Activity of Dihydropyridone Agonists of the Bile Acid Receptor TGR5
Univ. Lille, Inserm, Institut Pasteur de Lille, U1177─Drugs and Molecules for Living Systems, F-59000 Lille, France ...